A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Alzheimer's DiseaseMild Cognitive Impairment
Interventions
DRUG

florbetapir F 18

IV injection, 370MBq (10mCi), single dose

Trial Locations (15)

12208

Research Site, Albany

19046

Research Site, Jenkintown

27103

Research Site, Winston-Salem

33064

Research Site, Hallandale

33140

Research Site, Miami Beach

33351

Research Site, Sunrise

33407

Research Site, West Palm Beach

33702

Research Site, St. Petersburg

85006

Research Site, Phoenix

85210

Research Site, Sun City

85252

Research Site, Scottsdale

85741

Research Site, Tucson

92626

Research Site, Costa Mesa

06510

Research Site, New Haven

05201

Research Site, Bennington

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY